Nutex Health Inc. - Common Stock (NUTX)
90.05
+0.54 (0.60%)
NASDAQ · Last Trade: Aug 26th, 7:02 PM EDT
Detailed Quote
Previous Close | 89.51 |
---|---|
Open | 89.50 |
Bid | 90.10 |
Ask | 94.50 |
Day's Range | 82.55 - 91.09 |
52 Week Range | 17.51 - 184.27 |
Volume | 277,314 |
Market Cap | 497.84M |
PE Ratio (TTM) | 7.574 |
EPS (TTM) | 11.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 224,406 |
Chart
About Nutex Health Inc. - Common Stock (NUTX)
Nutex Health Inc. is a healthcare company that operates a network of technology-enabled outpatient health facilities, focusing on providing high-quality, accessible medical services. Their innovative approach combines advanced telehealth solutions with in-person care, allowing for comprehensive treatment options in various specialties. The company aims to enhance patient experiences and outcomes by leveraging technology to bridge the gap between in-office visits and remote healthcare delivery. By maintaining a patient-centric model, Nutex Health seeks to improve overall healthcare efficiency and accessibility in the communities it serves. Read More
News & Press Releases

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · August 26, 2025

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · August 26, 2025

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion.
By The Law Offices of Frank R. Cruz · Via Business Wire · August 26, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025. Nutex is a physician-led, healthcare services and operations company that began publicly trading via a reverse merger in April 2022.
By Robbins LLP · Via GlobeNewswire · August 25, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · August 25, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities during the period of August 8, 2024 through August 14, 2025, inclusive (“the Class Period”).
By Kirby McInerney LLP · Via GlobeNewswire · August 25, 2025
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · August 25, 2025
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
By Faruqi & Faruqi, LLP · Via Business Wire · August 25, 2025
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · August 25, 2025
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025. Nutex describes itself as a “physician-led, healthcare services and operations company.”
By The Rosen Law Firm, P.A. · Via Business Wire · August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
By Pomerantz LLP · Via GlobeNewswire · August 25, 2025
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NasdaqCM: NUTX), if they purchased the Company’s securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Texas.
By Kahn Swick & Foti, LLC · Via Business Wire · August 25, 2025
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 21, 2025
Via Benzinga · August 21, 2025
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutex Health Inc. (NASDAQ:NUTX), Anika Therapeutics, Inc. (NASDAQ:ANIK), Fluor Corporation (NYSE:FLR), and Inspire Medical Systems, Inc. (NYSE:INSP). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · August 20, 2025
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The investigation concerns whether Nutex and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · August 20, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · August 19, 2025
Law Offices of Howard G. Smith continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · August 18, 2025
The Law Offices of Frank R. Cruz continues its investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · August 18, 2025
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 17, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · August 15, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 13, 2025